Immunocore Holdings plc
IMCR
$33.98
-$0.50-1.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 430.78M | 412.81M | 400.02M | 379.59M | 356.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 430.78M | 412.81M | 400.02M | 379.59M | 356.15M |
| Cost of Revenue | 228.08M | 223.09M | 223.49M | 203.14M | 185.28M |
| Gross Profit | 202.70M | 189.72M | 176.53M | 176.45M | 170.87M |
| SG&A Expenses | 164.16M | 163.07M | 165.41M | 165.09M | 160.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -19.73M | -19.73M | -19.73M | -18.05M | -18.05M |
| Total Operating Expenses | 433.63M | 427.54M | 425.64M | 406.65M | 384.54M |
| Operating Income | -2.85M | -14.73M | -25.63M | -27.06M | -28.39M |
| Income Before Tax | -2.73M | -11.91M | -19.10M | -28.13M | -22.34M |
| Income Tax Expenses | 15.34M | 15.65M | 16.41M | 1.10M | -2.03M |
| Earnings from Continuing Operations | -18.07 | -27.57 | -35.51 | -29.23 | -20.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.07M | -27.57M | -35.51M | -29.23M | -20.31M |
| EBIT | -2.85M | -14.73M | -25.63M | -27.06M | -28.39M |
| EBITDA | 756.00K | -11.37M | -22.36M | -23.47M | -24.56M |
| EPS Basic | -0.36 | -0.55 | -0.70 | -0.58 | -0.40 |
| Normalized Basic EPS | -0.09 | -0.23 | -0.36 | -0.43 | -0.36 |
| EPS Diluted | -0.37 | -0.55 | -0.70 | -0.58 | -0.41 |
| Normalized Diluted EPS | -0.10 | -0.23 | -0.36 | -0.43 | -0.36 |
| Average Basic Shares Outstanding | 202.60M | 201.92M | 201.25M | 200.83M | 200.45M |
| Average Diluted Shares Outstanding | 204.78M | 204.10M | 203.11M | 202.69M | 205.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |